NASDAQ:SPPI

Spectrum Pharmaceuticals News Headlines

$2.87
-0.07 (-2.38 %)
(As of 04/13/2021 11:38 AM ET)
Add
Compare
Today's Range
$2.84
Now: $2.87
$2.97
50-Day Range
$2.90
MA: $3.37
$3.91
52-Week Range
$2.45
Now: $2.87
$5.24
Volume39,048 shs
Average Volume2.63 million shs
Market Capitalization$441.20 million
P/E RatioN/A
Dividend YieldN/A
Beta2.51

Headlines

Spectrum Pharmaceuticals (NASDAQ SPPI) News Headlines Today

SourceHeadline
Spectrum Pharmaceuticals (SPPI) Buy Rating Reiterated at B. RileySpectrum Pharmaceuticals' (SPPI) Buy Rating Reiterated at B. Riley
americanbankingnews.com - April 12 at 8:30 AM
Spectrum Pharmaceuticals Presentations at the Upcoming AACR Virtual Meeting 2021 to Include Updated Poziotinib Twice Daily Dosing DataSpectrum Pharmaceuticals Presentations at the Upcoming AACR Virtual Meeting 2021 to Include Updated Poziotinib Twice Daily Dosing Data
finance.yahoo.com - April 5 at 9:38 AM
Cantor Fitzgerald Research Analysts Lift Earnings Estimates for Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)Cantor Fitzgerald Research Analysts Lift Earnings Estimates for Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)
americanbankingnews.com - April 2 at 9:14 AM
Q1 2021 Earnings Estimate for Spectrum Pharmaceuticals, Inc. Issued By Jefferies Financial Group (NASDAQ:SPPI)Q1 2021 Earnings Estimate for Spectrum Pharmaceuticals, Inc. Issued By Jefferies Financial Group (NASDAQ:SPPI)
americanbankingnews.com - April 2 at 8:18 AM
Keith M. Mcgahan Sells 3,939 Shares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) StockKeith M. Mcgahan Sells 3,939 Shares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Stock
americanbankingnews.com - April 1 at 10:16 PM
Spectrum Pharmaceuticals, Inc. to Post FY2025 Earnings of $1.53 Per Share, Jefferies Financial Group Forecasts (NASDAQ:SPPI)Spectrum Pharmaceuticals, Inc. to Post FY2025 Earnings of $1.53 Per Share, Jefferies Financial Group Forecasts (NASDAQ:SPPI)
americanbankingnews.com - April 1 at 9:02 AM
Spectrum Pharmaceuticals (NASDAQ:SPPI) Announces Quarterly  Earnings Results, Meets EstimatesSpectrum Pharmaceuticals (NASDAQ:SPPI) Announces Quarterly Earnings Results, Meets Estimates
americanbankingnews.com - March 31 at 7:28 AM
BRIEF-Spectrum Pharmaceuticals Reports Fourth Quarter 2020 And Full Year 2020 Financial ResultsBRIEF-Spectrum Pharmaceuticals Reports Fourth Quarter 2020 And Full Year 2020 Financial Results
msn.com - March 30 at 8:05 PM
Spectrum Pharmaceuticals Reports Fourth Quarter 2020 and Full Year 2020 Financial Results and Pipeline UpdateSpectrum Pharmaceuticals Reports Fourth Quarter 2020 and Full Year 2020 Financial Results and Pipeline Update
finance.yahoo.com - March 30 at 8:04 PM
-$0.31 EPS Expected for Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) This Quarter-$0.31 EPS Expected for Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) This Quarter
americanbankingnews.com - March 29 at 2:26 PM
Spectrum Pharmaceuticals (SPPI) Scheduled to Post Quarterly Earnings on TuesdaySpectrum Pharmaceuticals (SPPI) Scheduled to Post Quarterly Earnings on Tuesday
americanbankingnews.com - March 29 at 8:34 AM
Spectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate UpdateSpectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
finance.yahoo.com - March 26 at 8:16 PM
Spectrum Pharmaceuticals Provides Update on ROLONTIS® (eflapegrastim) Pre-Approval InspectionSpectrum Pharmaceuticals Provides Update on ROLONTIS® (eflapegrastim) Pre-Approval Inspection
finance.yahoo.com - March 16 at 10:27 AM
Spectrums (SPPI) NSCLC Drug Gets FDAs Fast Track DesignationSpectrum's (SPPI) NSCLC Drug Gets FDA's Fast Track Designation
finance.yahoo.com - March 12 at 5:31 PM
FDA Grants Fast Track Designation to Spectrum Pharmaceuticals’ PoziotinibFDA Grants Fast Track Designation to Spectrum Pharmaceuticals’ Poziotinib
finance.yahoo.com - March 11 at 7:49 AM
How Much Of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Do Institutions Own?How Much Of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Do Institutions Own?
finance.yahoo.com - March 3 at 1:16 PM
Spectrum Pharmaceuticals Presents Twice Daily Dosing Data for Poziotinib at the ESMO TAT Virtual Congress 2021Spectrum Pharmaceuticals Presents Twice Daily Dosing Data for Poziotinib at the ESMO TAT Virtual Congress 2021
finance.yahoo.com - March 2 at 2:42 PM
Spectrum Pharmaceuticals Announces Poster Presentation at Upcoming Miami Breast Cancer ConferenceSpectrum Pharmaceuticals Announces Poster Presentation at Upcoming Miami Breast Cancer Conference
finance.yahoo.com - February 26 at 7:41 AM
Spectrum Pharmaceuticals Announces Two Presentations at Upcoming ESMO TAT Virtual Congress 2021Spectrum Pharmaceuticals Announces Two Presentations at Upcoming ESMO TAT Virtual Congress 2021
finance.yahoo.com - February 23 at 9:57 AM
Spectrum Pharmaceuticals to Participate in Guggenheim Healthcare Talks 2021 Oncology DaySpectrum Pharmaceuticals to Participate in Guggenheim Healthcare Talks 2021 Oncology Day
finance.yahoo.com - February 4 at 8:54 AM
Spectrum PharmaceuticalsSpectrum Pharmaceuticals
fool.com - January 31 at 10:15 PM
Spectrum Pharmaceuticals Announces Two Oral Presentations at Upcoming IASLC 2020 World Conference on Lung CancerSpectrum Pharmaceuticals Announces Two Oral Presentations at Upcoming IASLC 2020 World Conference on Lung Cancer
finance.yahoo.com - January 22 at 8:00 AM
Osteosarcoma Market Report | Major Factors Propelling Growth of Industry Size Valued By CAGR and Revenue Forecast Till 2025Osteosarcoma Market Report | Major Factors Propelling Growth of Industry Size Valued By CAGR and Revenue Forecast Till 2025
marketwatch.com - January 21 at 4:54 PM
Spectrum Pharmaceuticals to Participate in Three Upcoming Investor Conferences in JanuarySpectrum Pharmaceuticals to Participate in Three Upcoming Investor Conferences in January
finance.yahoo.com - January 5 at 9:08 AM
Spectrum Provides Poziotinib Update after Successful Pre-NDA Meeting with the FDASpectrum Provides Poziotinib Update after Successful Pre-NDA Meeting with the FDA
finance.yahoo.com - December 22 at 5:47 PM
Global Conjugated Monoclonal Antibodies Markets, 2020-2030: COVID-19 Growth, Impacts and ChangesGlobal Conjugated Monoclonal Antibodies Markets, 2020-2030: COVID-19 Growth, Impacts and Changes
benzinga.com - December 22 at 7:24 AM
Spectrum Pharmaceuticals Appoints Nora Brennan to Board of DirectorsSpectrum Pharmaceuticals Appoints Nora Brennan to Board of Directors
finance.yahoo.com - December 14 at 9:19 AM
Is SPPI A Good Stock To Buy Now?Is SPPI A Good Stock To Buy Now?
finance.yahoo.com - December 14 at 9:19 AM
Spectrum Pharmaceuticals Announces Three Poster Presentations at Upcoming San Antonio Breast Cancer SymposiumSpectrum Pharmaceuticals Announces Three Poster Presentations at Upcoming San Antonio Breast Cancer Symposium
finance.yahoo.com - December 4 at 5:35 PM
FDA delays decision on Bristol Myers cancer therapy due to COVID-19 travel curbsFDA delays decision on Bristol Myers cancer therapy due to COVID-19 travel curbs
finance.yahoo.com - November 16 at 6:56 PM
Spectrum Shareholders In Limbo As FDA Delays Rolontis Decision Date, Agrees To Discuss PoziotinibSpectrum Shareholders In Limbo As FDA Delays Rolontis Decision Date, Agrees To Discuss Poziotinib
seekingalpha.com - November 11 at 8:02 AM
Spectrum Pharmaceuticals to Present at Two Upcoming Investor Conferences in NovemberSpectrum Pharmaceuticals to Present at Two Upcoming Investor Conferences in November
finance.yahoo.com - November 9 at 8:33 AM
Spectrum Pharmaceuticals Inc (SPPI) Q3 2020 Earnings Call TranscriptSpectrum Pharmaceuticals Inc (SPPI) Q3 2020 Earnings Call Transcript
finance.yahoo.com - November 5 at 12:27 AM
Spectrum Pharmaceuticals EPS misses by $0.02Spectrum Pharmaceuticals EPS misses by $0.02
seekingalpha.com - November 4 at 7:26 PM
Recap: Spectrum Pharmaceuticals Q3 EarningsRecap: Spectrum Pharmaceuticals Q3 Earnings
benzinga.com - November 4 at 7:26 PM
Spectrum Pharmaceuticals (SPPI) Reports Q3 Loss, Misses Revenue EstimatesSpectrum Pharmaceuticals (SPPI) Reports Q3 Loss, Misses Revenue Estimates
finance.yahoo.com - November 4 at 7:26 PM
Spectrum Pharmaceuticals to Report Third Quarter 2020 Financial Results and Provide Corporate UpdateSpectrum Pharmaceuticals to Report Third Quarter 2020 Financial Results and Provide Corporate Update
markets.businessinsider.com - October 28 at 7:26 AM
FDA delays action on Spectrums Rolontis application pending on-site inspectionFDA delays action on Spectrum's Rolontis application pending on-site inspection
seekingalpha.com - October 26 at 5:36 PM
FDA delays approval of Spectrum Pharmas drug due to COVID-19FDA delays approval of Spectrum Pharma's drug due to COVID-19
nasdaq.com - October 26 at 12:35 PM
FDA delays action on Spectrums Relontis application pending on-site inspectionFDA delays action on Spectrum's Relontis application pending on-site inspection
seekingalpha.com - October 26 at 12:35 PM
FDA Delays Decision On Spectrums Neutropenia Drug Due To COVID-19 Related Travel RestrictionsFDA Delays Decision On Spectrum's Neutropenia Drug Due To COVID-19 Related Travel Restrictions
nasdaq.com - October 26 at 12:35 PM
Spectrum Pharmaceuticals Announces that the FDA is Deferring its Action on the BLA for ROLONTIS® (eflapegrastim)Spectrum Pharmaceuticals Announces that the FDA is Deferring its Action on the BLA for ROLONTIS® (eflapegrastim)
finance.yahoo.com - October 26 at 7:34 AM
FDA delays approval of Spectrum Pharma's drug due to COVID-19FDA delays approval of Spectrum Pharma's drug due to COVID-19
finance.yahoo.com - October 26 at 7:34 AM
SPPI.OQ - Spectrum Pharmaceuticals, Inc. Profile | ReutersSPPI.OQ - Spectrum Pharmaceuticals, Inc. Profile | Reuters
reuters.com - October 8 at 7:53 AM
Spectrum Pharmaceuticals (SPPI) Jumps: Stock Rises 7%Spectrum Pharmaceuticals (SPPI) Jumps: Stock Rises 7%
finance.yahoo.com - September 21 at 1:31 PM
Spectrum Pharma reports positive new data for poziotinib in lung cancer patientsSpectrum Pharma reports positive new data for poziotinib in lung cancer patients
seekingalpha.com - September 18 at 9:07 AM
Spectrum Pharmaceuticals Presents Results in HER2 Exon 20 Insertion Mutations from Cohort 2 of the Poziotinib ZENITH20 Clinical TrialSpectrum Pharmaceuticals Presents Results in HER2 Exon 20 Insertion Mutations from Cohort 2 of the Poziotinib ZENITH20 Clinical Trial
finance.yahoo.com - September 18 at 9:07 AM
Why Spectrum Pharmaceuticals Is Trading Higher TodayWhy Spectrum Pharmaceuticals Is Trading Higher Today
benzinga.com - September 17 at 11:06 PM
Spectrum cheers JMP Securities Outperform ratingSpectrum cheers JMP Securities Outperform rating
seekingalpha.com - September 17 at 6:06 PM
Implied Volatility Surging for Spectrum (SPPI) Stock OptionsImplied Volatility Surging for Spectrum (SPPI) Stock Options
finance.yahoo.com - September 16 at 10:38 AM
This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.